... vein thrombosis Anticoagulant therapy Heparin Low molecular weight heparin Warfarin Randomized trials Haemostasis 1996; 26 (Suppl 4): 220-226 MANAGEMENT OF VENOUS THROMBOEMBOLISM: OPTIMIZATION BY CLINICAL TRIALS Dr. Alexander G.G. Turpie McMaster University Hamilton. Ontario. Canada Key words...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Anticoagulant therapy Optimal therapeutic range Haemostasis 15: 283-292 (1985) ©1985 S. Karger AG, Basel 0301-0147/85/0154-0283S2.75/0 Optimal...

.... Prothrombin determination Micro-coagulation assay Thrombin generation Anticoagulant therapy Original Papers Haemostasis 13: 1-8 (1983) ©1983 S. Karger AG, Basel 0301-0147/83/0131-0001 $2.75/0 Determination of Prothrombin by a Micro-Coagulation Method B. Kirchhof, S. Schmale, J. van de Loo Department...

... reported in other clinical trials with ASA, suggest that ASA treatment is beneficial in patients who have survived a myocardial infarct. Acetylsalicylic acid Anticoagulant therapy Myocardial infarction Secondary prevention Sudden death Haemostasis 9: 325-344 (1980) Secondary Prevention...

... anticoagulant therapy, both in the therapeutic range and in a case of overdosage. As is the case in coagulation tests, heparin therapy remains a disturbing circumstance. The prothrombin concentration was measured (a) in the plasma of 50 long-term anticoagulated patients, and the results were compared with those...

.... It is recommended that LMWH should be administered for 5–10 days and should overlap with oral anticoagulant therapy by at least 4 days. Surgical pulmonary embolectomy should only be considered in patients with life-threatening pulmonary embolism who have failed to respond during the first 3 h of thrombolytic...

... the way to the use of rFVIIa in general haemostasis. Inhibitors Thrombin Safety Traumata Anticoagulant therapy Impaired liver function © 2002 S. Karger AG, Basel 2002 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated...